ロード中...
In vitro study on the role of SOX9 in trastuzumab resistance of adenocarcinoma of the esophagogastric junction
Trastuzumab is recommended for the treatment of human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagogastric junction (AEG) in combination with chemotherapy; however, drug resistance has severely affected its clinical application. The present study aimed to investigate the...
保存先:
| 出版年: | Exp Ther Med |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
D.A. Spandidos
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5795639/ https://ncbi.nlm.nih.gov/pubmed/29456713 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.5744 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|